WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuParasitic infections
Ouvrir ce répertoire et afficher son contenuInsect and arachnid bites and stings
Ouvrir ce répertoire et afficher son contenuSuperficial fungal infections
Ouvrir ce répertoire et afficher son contenuSubcutaneous fungal infections
Ouvrir ce répertoire et afficher son contenuBacterial infections
Ouvrir ce répertoire et afficher son contenuViral infections
Ouvrir ce répertoire et afficher son contenuEczematous diseases
Ouvrir ce répertoire et afficher son contenuScaling diseases
Ouvrir ce répertoire et afficher son contenuPapulosquamous diseases
Afficher le documentCutaneous reactions to drugs
Ouvrir ce répertoire et afficher son contenuPigmentary disorders
Ouvrir ce répertoire et afficher son contenuPremalignant lesions and malignant tumours
Ouvrir ce répertoire et afficher son contenuPhotodermatoses
Ouvrir ce répertoire et afficher son contenuBullous dermatoses
Afficher le documentAlopecia areata
Afficher le documentUrticaria
Ouvrir ce répertoire et afficher son contenuConditions common in children
Afficher le documentAcne vulgaris
Afficher le documentPruritus
Afficher le documentTropical ulcers
Ouvrir ce répertoire et afficher son contenuAntimicrobial drugs
Ouvrir ce répertoire et afficher son contenuAntifugal drugs
Ouvrir ce répertoire et afficher son contenuAntiseptic agents
Ouvrir ce répertoire et afficher son contenuKeratoplastic and keratolytic agents
Ouvrir ce répertoire et afficher son contenuScabicides and pediculicides
Ouvrir ce répertoire et afficher son contenuAnti-inflammatory and antipruritic drugs1
Ouvrir ce répertoire et afficher son contenuAntiallergics and drugs used in anaphylaxis
Ouvrir ce répertoire et afficher son contenuUltraviolet radiation-blocking agents (sunscreens)
Ouvrir ce répertoire et afficher son contenuMiscellaneous drugs
Fermer ce répertoireAnnex
Afficher le documentClassification of topical corticosteroids
Afficher le documentSelected WHO Publications of Related Interest
Afficher le documentBack cover
 

Classification of topical corticosteroids

Hydrocortisone and betamethasone are examples of low- and high-potency topical corticosteroids. Topical corticosteroids have been ranked in terms of potency into four groups consisting of seven classes. Class I topical corticosteroids are the most potent and Class VII are the least potent. Efficacy and side-effects are greatest with the Class I ultra-high-potency preparations which should only be used for limited time periods (2-3 weeks). Representative preparations by group are listed in the table below. These groups may vary depending on the formulation and concentration and should be considered approximate. In general, ointments are more potent than creams or lotions. Potency is also increased when topical corticosteroids are used under occlusive dressings or in intertriginous areas.

Potency

Class

Topical corticosteroid

Formulation

Ultra high

I

Clobetasol propionate

Cream, 0.05%

   

Diflorasone diacetate

Ointment, 0.05%

High

II

Amcinonide

Ointment, 0.1%

   

Betamethasone dipropionate

Ointment, 0.05%

   

Desoximetasone

Cream or ointment, 0.025%

   

Fluocinonide

Cream, ointment or gel, 0.05%

   

Halcinonide

Cream, 0.1%

 

III

Betamethasone dipropionate

Cream, 0.05%

   

Betamethasone valerate

Ointment, 0.1%

   

Diflorasone diacetate

Cream, 0.05%

   

Triamcinolone acetonide

Ointment, 0.1%

Moderate

IV

Desoximetasone

Cream, 0.05%

   

Fluocinolone acetonide

Ointment, 0.025%

   

Fludroxycortide

Ointment, 0.05%

   

Hydrocortisone valerate

Ointment, 0.2%

   

Triamcinolone acetonide

Cream, 0.1%

 

V

Betamethasone dipropionate

Lotion, 0.02%

   

Betamethasone valerate

Cream, 0.1%

   

Fluocinolone acetonide

Cream, 0.025%

   

Fludroxycortide

Cream, 0.05%

   

Hydrocortisone butyrate

Cream, 0.1%

   

Hydrocortisone valerate

Cream, 0.2%

   

Triamcinolone acetonide

Lotion, 0.1%

Low

VI

Betamethasone valerate

Lotion, 0.05%

   

Desonide

Cream, 0.05%

   

Fluocinolone acetonide

Solution, 0.01%

 

VII

Dexamethasone sodium phosphate

Cream, 0.1%

   

Hydrocortisone acetate

Cream, 1%

   

Methylprednisolone acetate

Cream, 0.25%

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012